<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00245700</url>
  </required_header>
  <id_info>
    <org_study_id>R050017</org_study_id>
    <secondary_id>Grant from Orion Pharma</secondary_id>
    <nct_id>NCT00245700</nct_id>
  </id_info>
  <brief_title>Adherence of Stalevo, Entacapone and Levodopa</brief_title>
  <official_title>Study of Adherence of Stalevo, Entacapone and Levodopa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Glasgow University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Glasgow University Hospitals NHS Trust</source>
  <brief_summary>
    <textblock>
      To test if combining two antiparkinson drugs into a single tablet improves accuracy of
      medicine intake by the patient.

      To test if patients with Parkinson's disease who take medicines at regular time intervals
      have smoother symptom control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">July 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>14</enrollment>
  <condition>Parkinson's Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with Parkinson's disease aged between 18 and 85 years fulfilling UK
             Brain Bank criteria.

          -  Current levodopa therapy prescribed on a regular basis three or more times per day but
             requiring entacapone because of 'wearing off'

          -  Able to manipulate electronic monitoring bottles and complete questionnaires

        Exclusion Criteria:

          -  Current use of compliance aid such that study participation would be detrimental to
             patient's adherence

          -  Pregnancy or breast feeding

          -  Excess alcohol (over 21 units per week for women and 28 units for men)

          -  Mini mental state examination of less than 26.

          -  Severe depression (Geriatric depression score over 20)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Donald G Grosset, MBChB, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Southern General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2005</study_first_submitted>
  <study_first_submitted_qc>October 27, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2005</study_first_posted>
  <last_update_submitted>May 22, 2008</last_update_submitted>
  <last_update_submitted_qc>May 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr D Grosset</name_title>
    <organization>Southern General Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levodopa</mesh_term>
    <mesh_term>Entacapone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

